MEDICINOVA, INC. v. GENZYME CORPORATION , No. 20-1064 (Fed. Cir. 2020)
Annotate this Case
Download PDF
Case: 20-1064 Document: 70 Page: 1 Filed: 12/14/2020 NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ MEDICINOVA, INC., A DELAWARE CORPORATION, Plaintiff-Appellant v. GENZYME CORPORATION, A MASSACHUSETTS CORPORATION, Defendant-Appellee ______________________ 2020-1064 ______________________ Appeal from the United States District Court for the Southern District of California in No. 3:14-cv-02513-JLSKSC, Judge Janis L. Sammartino. ______________________ JUDGMENT ______________________ BRUCE G. CHAPMAN, Sheppard, Mullin, Richter & Hampton LLP, Los Angeles, CA, argued for plaintiff-appellant. Also represented by DON PELTO, Washington, DC; MATTHEW G. HALGREN, MARK GERARD RACKERS, San Diego, CA. FRANCIS DIGIOVANNI, Faegre Drinker Biddle & Reath LLP, Wilmington, DE, argued for defendant-appellee. Also Case: 20-1064 Document: 70 Page: 2 Filed: 12/14/2020 represented by MICHAEL CURT LAMBERT, THATCHER A. RAHMEIER; RABIYA KADER, Sanofi, Bridgewater, NJ. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (DYK, BRYSON, and O’MALLEY, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT December 14, 2020 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
